Searchable abstracts of presentations at key conferences in endocrinology

ea0081p529 | Adrenal and Cardiovascular Endocrinology | ECE2022

Characteristics of patients with life-threatening events in pheochromocytoma

Lider-Burciulescu Sofia-Maria , Gheorghiu Monica Livia , Badiu Corin

Introduction: Pheochromocytomas and paragangliomas (PPGLs) are rare tumors of the chromaffin tissue characterised by catecholamine excess. Cardiovascular complications, such as hypertensive crisis and catecholamine-induced cardiomyopathy, are known to be the most frequent causes of life-threatening events in PPGLs patients.Design: We analysed records of patients diagnosed with PPGLs in one referral centre from Romania between 1976 and 2021 (n= 1...

ea0090ep38 | Adrenal and Cardiovascular Endocrinology | ECE2023

Bilateral pheochromocytomas-recurrence and adrenal insufficiency rate related to surgical technique and genetic status

Lider-Burciulescu Sofia-Maria , Gheorghiu Monica Livia , Victor Tomulescu , Badiu Corin

Introduction: Bilateral pheochromocytomas (PHEOs) most often occur as components of hereditary syndromes: MEN2A, VHL disease or neurofibromatosis. The best surgical technique in such cases is yet disputed between cortical sparing or total adrenalectomy. Two important complications are related to each surgical technique: adrenal insufficiency (AI) or recurrence-which one is more harmful for the patient?Aim: To evaluate the complications (recurrence, AI) r...

ea0074ncc27 | Highlighted Cases | SFENCC2021

Hyperandrogenism and breast cancer in a postmenopausal woman – treatment challenges

Lider Burciulescu Sofia Maria , Dumitrascu Anda , Vladoiu Suzana , Caragheorgheopol Anda , Gheorghiu Monica Livia

Introduction: New-onset hyperandrogenism is rare in postmenopausal women and is usually associated with causes such as ovarian hyperthecosis, androgen-secreting tumor or medication. Patients with hyperandrogenism and breast cancer need a special attention when choosing the treatment.Case history: A 46-year old woman diagnosed with hormone receptor-positive breast cancer at 37 years old, for which she underwent surgery, chemotherapy, radiotherapy and horm...